| Followers | 75 |
| Posts | 3712 |
| Boards Moderated | 0 |
| Alias Born | 10/23/2010 |
Thursday, April 21, 2011 4:27:47 PM
Newfield Resources (NFX): In fiscal 2010, NFX reported total revenues of $1.9 billion, an increase of 46% compared with a year ago. Annual net income was $523 million in FY 2010. NFX recently traded at $72.11 and gained 0.7% since the end of last year. The stock has a market cap of $9.5 billion and a P/E ratio of 18.56.
This is not an offer to buy or sell securities or any kind of investment advice. Oil investment carries very high risks so consult a licensed professional making any decisions. My resume is real time on Twitter @TurnKeyOil.
Recent NFX News
- Rainbow Rare Earth highlights assessment at Uberaba • Alliance News • 03/12/2026 01:25:11 AM
- Nuformix PLC £1.0 million Placing • RNS Regulatory News • 03/11/2026 07:00:07 AM
- Cloudcoco's "transformative" year; CEPS pays debt • Alliance News • 03/10/2026 04:34:29 PM
- Nuformix Secures U.S. Orphan Drug Designation for IPF Therapy Candidate NXP002 • UK Market News • 03/10/2026 08:22:59 AM
- Nuformix PLC Confirmation of US ODD for NXP002 in IPF • RNS Regulatory News • 03/10/2026 07:00:11 AM
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/03/2026 10:05:00 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • RNS Regulatory News • 02/05/2026 12:00:01 PM
- Nuformix focused on lead asset for pulmonary fibrosis as loss narrows • Alliance News • 01/27/2026 02:23:24 PM
- Nuformix PLC Annual Results for period ended 30 September 2025 • RNS Regulatory News • 01/27/2026 07:00:07 AM
- Nuformix PLC Total Voting Rights • RNS Regulatory News • 11/28/2025 03:22:23 PM
- Nuformix raises GBP228,000 in open offer • Alliance News • 11/12/2025 04:59:02 PM
- Celsius raises funds; Built Cybernetics acquisition • Alliance News • 11/12/2025 03:40:10 PM
- Nuformix Awaits FDA Feedback on Orphan Drug Status for IPF Therapy • UK Market News • 11/12/2025 08:28:10 AM
- *Nuformix to issue 114.0m shares at 0.2p for gross proceeds GBP228,081 • Alliance News • 11/12/2025 07:46:33 AM
- Nuformix PLC Update re. US FDA ODD Application • RNS Regulatory News • 11/12/2025 07:01:00 AM
- Nuformix PLC Results of Underwritten Open Offer • RNS Regulatory News • 11/12/2025 07:00:09 AM
- Nuformix launches £228,081 open offer to accelerate fibrosis and oncology programs • UK Market News • 10/28/2025 08:30:52 AM
- Nuformix PLC Underwritten Open Offer • RNS Regulatory News • 10/28/2025 07:00:08 AM
- Nuformix Appoints New Auditor as Part of Strategic Progress • UK Market News • 10/10/2025 07:12:35 AM
- Nuformix PLC Change of Auditor • RNS Regulatory News • 10/10/2025 06:00:10 AM
- Nuformix PLC European Respiratory Society Congress Attendance • RNS Non-Regulatory • 09/25/2025 06:00:13 AM
- Nuformix submits FDA drug designation application for NXP002 • Alliance News • 08/11/2025 11:11:14 AM
- Nuformix PLC US FDA ODD Application Submitted for NXP002 • RNS Regulatory News • 08/11/2025 06:00:09 AM
- Nuformix PLC Total Voting Rights • RNS Regulatory News • 05/30/2025 01:24:44 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
